About VYRSA Technologies
VYRSA Technologies was founded in 2021 and is based in King Of Prussia, United States. Operations are centered in the spine and medical technology sector, with a focus on sacroiliac joint fusion. A comprehensive toolset for minimally invasive surgery approaches, including posterior, lateral, and hybrid methods, is provided. The VYRSApro allograft implant is used in posterior SI joint fusion procedures by physicians.
- Headquarter King Of Prussia, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vyrsa Technologies, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of VYRSA Technologies
Detailed funding history for VYRSA Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in VYRSA Technologies
VYRSA Technologies has secured backing from 1 investor. Prominent investors backing the company include Nevro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of high-frequency spinal cord stimulation implants
|
Locked | Locked | Locked |
Investor details for VYRSA Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VYRSA Technologies
Investment portfolio details for VYRSA Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VYRSA Technologies
Detailed financials for VYRSA Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vyrsa Technologies Comparisons
Peer comparison for VYRSA Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VYRSA Technologies
Detailed competitors of VYRSA Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vyrsa Technologies
Complete news archive for VYRSA Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VYRSA Technologies
VYRSA Technologies was founded in 2021.
VYRSA Technologies is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Kevin Thornal is the current CEO of VYRSA Technologies.
VYRSA Technologies was founded in 2021 and is based in King Of Prussia, United States. Operations are centered in the spine and medical technology sector, with a focus on sacroiliac joint fusion. A comprehensive toolset for minimally invasive surgery approaches, including posterior, lateral, and hybrid methods, is provided. The VYRSApro allograft implant is used in posterior SI joint fusion procedures by physicians.
VYRSA Technologies has 1 investor. Key investors include Nevro.